Global Clinical Diagnostics Automation Market

  • May 2014
  • -
  • Global Industry Analysts
  • -
  • 275 pages

This report analyzes the worldwide markets for Clinical Diagnostics Automation in US$ Thousands by the following Product Segments: Automated Analyzers, Stand-alone Automation, and Total Lab Automation. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as -

Abaxis, Inc.
Abbott Diagnostics, Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company
bioMérieux SA

Table Of Contents




I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Market Segmentation I-3
Automated Analyzers I-3
Stand-Alone Automation I-4
Total Laboratory Automation I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
Changing Attitude towards Automation in Clinical Diagnostic
Laboratories II-1
Primary Factors Encouraging Laboratories to Embrace
Automation - In A Nutshell II-2
Automation - A Panacea to the Laboratories’ Plight II-3
The Road Ahead for Clinical Diagnostics Automation II-4
Drivers, Trends and Challenges in the Global Lab Automation
Market - At a Glance II-5
Growth Drivers II-5
Trends II-5
Issues and Challenges II-6
Despite Challenges, Emerging Markets Provide Growth
Opportunities II-6
Developed Nations: Cost Pressures Necessitate New Strategies II-7
Regulatory Environment II-8
Competition II-8
Table 1: Leading Players in the Global Laboratory Automation
Market (2011): Percentage Breakdown of Value Sales for
Danaher, Eppendorf, Perkin Elmer, Tecan, Thermo and Others
(includes corresponding Graph/Chart) II-8

2. MARKET TRENDS, DRIVERS AND ISSUES II-9
Need for High-Quality Healthcare Drives Demand for Clinical
Diagnostics Automation II-9
Rising Investments in Biotechnology - A Key Growth Driver II-9
Clinical Diagnostics Automation - A Vital Tool in Patient
Treatment Management II-10
Need to Reduce Turnaround Times - A Major Growth Factor II-10
Increasing Healthcare Spending in Emerging Markets -
Opportunity for growth II-11
Table 2: Healthcare Spending as % of GDP in Select Countries
(2011) (includes corresponding Graph/Chart) II-11
Healthcare Needs of Aging Population - An Important
Opportunity Indicator II-11
Table 3: Elderly Population (60+ Years) as a Percentage of
Total Population (2012 and 2050) (includes corresponding
Graph/Chart) II-12

Table 4: Global Aging Population (60+) and their Proportion
of Total Population (2012 and 2050) (includes corresponding
Graph/Chart) II-13
Rapid Detection of Infectious Diseases: Enhancing Need for
Clinical Laboratory Automation Equipment II-14
Table 5: Reported Cases of Major Infectious by Geographic
Region (2011) II-14
Rising Incidence of Cancer to Propels Demand for Clinical
Diagnostics Automation II-14
Table 6: World Cancer Incidence by Geographic Region and
Gender (2012): Number of New Cancer Cases Reported in
Thousands for Asia-Oceania, Europe, North America, Latin
America and the Caribbean, and Africa (includes corresponding
Graph/Chart) II-15

Table 7: New Cancer Cases in the World by Affected Site: 2012
(in Thousands) (includes corresponding Graph/Chart) II-16

Table 8: World Cancer Mortality by Geographic Region and
Gender (2012): Number of Cancer-Related Deaths in Thousands
for Asia-Oceania, Europe, North America, Latin America and the
Caribbean, and Africa (includes corresponding Graph/Chart) II-17

Table 9: Global Incidence of Common Cancers in Men (2012):
Number of New Cases Reported in Thousands for Lung and
Bronchus, Prostate, Colorectal and Liver Cancers (includes
corresponding Graph/Chart) II-17

Table 10: Global Incidence of Common Cancers in Women (2012):
Number of New Cases Reported in Thousands for Breast,
Colorectal, Lung and Bronchus and Liver Cancers (includes
corresponding Graph/Chart) II-18

Table 11: Global Cancer Mortality in Men for Select Cancers
(2012): Number of Deaths in Thousands for Lung and Bronchus,
Liver, Colorectal and Prostate Cancers (includes
corresponding Graph/Chart) II-18

Table 12: Global Cancer Mortality in Women for Select Cancers
(2012): Number of Deaths in Thousands for Breast, Lung and
Bronchus, Colorectal and Liver Cancer Prone Sites based on
Age (includes corresponding Graph/Chart) II-18
Cancer Prone Sites based on Age II-19
End-User and Technology-Led Aspects Drive Demand for Automation II-19
Automation - The Prime Solution to Enhance Laboratory Efficiency II-19
Total Laboratory Automation - Only Good Enough for Large
Hospitals II-19
Large Hospitals See Good Return on Investments by TLA II-20
Issues Continue to Plague Large Scale Automation Solutions II-20
Bright Prospects Ahead for TLA II-20
Modular Automation Surges Ahead of TLA in Adoption II-21
Rising Demand for Automated Hematology Analyzers II-22
Technological Advancements and Rising Awareness Levels Drive
Growth in the Global Biochemistry Analyzers Market II-22
Demand for POC Testing Rises II-23
Automation Liberates Patients from Risk of Pre-analytical
Diagnostic Errors II-23
Blood Gas Analyzers - A Potential Solution to Reduce Time Lag
Between Testing and Results II-24
Point-of-care Testing - A Revolution in the Blood Gas and
Electrolyte Analyzers Market II-24
Automated Multiplexing Technology: Major Role in Clinical
Diagnostics Automation II-25
Multiplex Testing for Herpes Simplex Virus Type 1 and 2 II-26
Microbiology Labs: Growing Need for Automation II-26
Automation to Provide Impetus to New Businesses II-27
Internet Revolutionizes Laboratory Diagnostics II-27
System Compatibility: A Key Requirement II-28
Labor Shortage: A Key Challenge in the Clinical Lab Automation
Market II-28
Clinical Diagnostics Automation to Insulate Effects of
Tightening Labor Market II-28
Bar Code Technology Continues to Gain Adoption in Clinical
Settings II-29
Barcoding Eases Specimen and Consumable Identification II-29
Bar Code Labeling Protects Patient Safety II-30
Benefits of Barcoding to Medical Device Manufacturers II-30
Laboratory Information System - A Key Aspect of Clinical
Diagnostics Automation II-31
Operational Concerns Associated with LIS II-31

3. CLINICAL DIAGNOSTICS AUTOMATION - AN OVERVIEW II-32
Laboratory Automation: Order of the Day II-32
Benefits of Laboratory Automation II-32
Introduction to Clinical Diagnostics Automation II-32
Evolution of Clinical Diagnostics Automation II-33
Components of Laboratory Automation System II-33
Typical Diagnostic Laboratory Structure II-33
Laboratory Control and Information System II-34
Sample Storage II-34
Sample Preparation II-34
Transportation II-34
Analysis II-34
Clinical Diagnostics Automation by Market Segment II-35
Automated Analyzers II-35
Stand-Alone Automation II-35
Total Laboratory Automation (TLA) II-35
Limitations of TLA Systems II-36
Modular Automation: Emerging Alternative II-36
Total Laboratory Automation (TLA) Vs. Modular Laboratory
Automation II-36
Decentralized Testing Gains Importance II-36
Advantages of POC Testing Over Centralized Laboratory Testing II-37
Cost Analysis of POC Testing Vs. Laboratory Testing II-37
Cost Savings through Space Savings II-38
Major Components of Multi-Step Automation Process II-38
Consolidation of Workstation II-38
Information Management II-38

4. PRODUCT INTRODUCTIONS/INNOVATIONS II-39
Hamilton Unveils LabElite Range of Automated Benchtop Devices II-39
Axiom Veterinary Laboratories Rolled out MiLab Range II-39
Transasia Unveils Five New Automated Lab Instruments II-39
Transasia Bio-Medicals Unveils Sysmex XN Series Differential
Haematology Analyser II-39
Immunetics Launches BacTx Analyzer for Use with BacTx Rapid Test II-39
SIEMENS Launches VersaCell X3 Solution II-39
Roche Launches cobas 8100 Automated Workflow Series II-39
Roche Launches cobas® 6800 and cobas® 8800 Systems II-40
Abbott Launches ACCELERATOR® a3600 Next Generation Automation
Solution II-40
Beckman Coulter Launches UniCel DxH 600 Benchtop Hematology
Analyzer II-40
Microscan Unveiled Auto ID and Machine Vision Technologies Line II-40
Siemens Unveils Sysmex® CS-5100 System II-40
Siemens Launches Aptioâ„¢ Automation II-40
Roche Launches cobas p 312 Pre-Analytical System II-40
Randox Unveils RX Daytona Compact Clinical Chemistry Analyser II-40

5. RECENT INDUSTRY ACTIVITY II-41
Carlyle Group to Acquire Ortho-Clinical Diagnostics II-41
Singulex Partners with Tecan for Commercial Development of
Ultrasensitive Sgx Clarityâ„¢ System II-41
Roche and Hitachi Renew Development and Manufacturing Contract II-41
Sysmex America Inks Distribution Agreement with Henry Schein II-41
ERBA Diagnostics Receives FDA Approval for XL200 Clinical
Chemistry Analyzer II-41
Abaxis Receives Health Canada Class III Clearance for Piccolo
Xpress® II-41
NorDx to Acquire Sysmex® XN-Series Automated Hematology Analyzers II-42
Francisco Partners Takes over McKesson’s Hospital Automation Unit II-42
Cerner Takes over Labotix Automation II-42
Bio-Rad Enters into Development Agreement with Inpeco II-42
CryoXtractâ„¢ Inks Distribution Agreement with Bio-Strategy Ltd II-42
CML HealthCare Enters into Vendor Supply Agreement with Sysmex
Canada II-42
BD Completes Takeover of KIESTRA Lab Automation BV II-42
Sysmex America Receives FDA Clearance of XN-Series Hematology
Analyzers Products II-43
IRIS International Inked Distribution Agreement with Alifax II-43

6. FOCUS ON SELECT GLOBAL PLAYERS II-44
Abaxis, Inc. (US) II-44
Abbott Diagnostics, Inc. (US) II-44
Beckman Coulter, Inc. (US) II-45
Becton, Dickinson and Company (US) II-45
bioMerieux SA (France) II-46
Bio-Rad Laboratories, Inc. (US) II-46
Diagnostica Stago (France) II-47
Eppendorf AG (Germany) II-47
F. Hoffmann-La Roche Ltd. (Switzerland) II-47
HORIBA ABX S.A.S. (France) II-47
Hudson Robotics, Inc. (US) II-48
Ortho Clinical Diagnostics, Inc. (US) II-48
PerkinElmer Inc. (US) II-48
QIAGEN NV (The Netherlands) II-49
Siemens Healthcare Diagnostics, Inc. (US) II-49
Sysmex America, Inc. (US) II-49
Tecan Group Ltd. (Switzerland) II-50
The ELITechGroup SAS (France) II-50
Thermo Fisher Scientific, Inc. (US) II-51

7. GLOBAL MARKET PERSPECTIVE II-52
Table 13: World Recent Past, Current and Future Analysis for
Clinical Diagnostics Automation by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America, and Rest of World Markets Independently Analyzed with
Annual Revenue Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) II-52

Table 14: World Historic Review for Clinical Diagnostics
Automation by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America, and Rest of
World Markets Independently Analyzed with Annual Revenue
Figures in US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-53

Table 15: World 15-Year Perspective for Clinical Diagnostics
Automation by Geographic Region - Percentage Breakdown of
Revenues for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America, and Rest of World Markets
for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) II-54

Table 16: World Recent Past, Current and Future Analysis for
Automated Analyzers by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America, and
Rest of World Markets Independently Analyzed with Annual
Revenue Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) II-55

Table 17: World Historic Review for Automated Analyzers by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America, and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-56

Table 18: World 15-Year Perspective for Automated Analyzers by
Geographic Region - Percentage Breakdown of Revenues for US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America, and Rest of World Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) II-57

Table 19: World Recent Past, Current and Future Analysis for
Total Lab Automation by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America, and
Rest of World Markets Independently Analyzed with Annual
Revenue Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) II-58

Table 20: World Historic Review for Total Lab Automation by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America, and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-59

Table 21: World 15-Year Perspective for Total Lab Automation
by Geographic Region - Percentage Breakdown of Revenues for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America, and Rest of World Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-60

Table 22: World Recent Past, Current and Future Analysis for
Stand-alone Automation by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America,
and Rest of World Markets Independently Analyzed with Annual
Revenue Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) II-61

Table 23: World Historic Review for Stand-alone Automation by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America, and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-62

Table 24: World 15-Year Perspective for Stand-alone Automation
by Geographic Region - Percentage Breakdown of Revenues for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America, and Rest of World Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-63


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Healthcare Industry Dynamics Augur Well for Lab Automation III-1
Table 25: Healthcare Spending as a % of GDP (includes
corresponding Graph/Chart) III-2
Growing Complexity of Tests Necessitates Automation of Lab
Operations III-3
Increasing Pressure on Healthcare Organizations Fuels
Adoption of Laboratory Automation Systems III-3
Shortage of Qualified Lab Workforce: A Major Growth Driver III-4
Table 26: Overall Vacancy Rates (%) by Laboratory
Departments for the Year 2012 (includes corresponding
Graph/Chart) III-5
Rising Diagnostic Needs of Aging Population III-5
Table 27: North American Elderly Population by Age Group
(1975-2050) (includes corresponding Graph/Chart) III-6
Table 28: US Population Breakdown by Age Group (2012) (
includes corresponding Graph/Chart) III-7
TLA Systems: Improving Quality and Turnaround Times III-7
Modular Automation Scores over Total Laboratory Automation
Approach III-7
Automation Ensures Error-Free and Faster Test Results III-8
Regulations Dictate Technological Changes in Laboratories III-8
FDA Regulations and Classification of Devices in Clinical
Laboratory Automation III-8
Product launches III-9
Strategic corporate developments III-11
Key Players III-13
B.Market Analytics III-18
Table 29: US Recent Past, Current and Future Analysis for
Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-18

Table 30: US Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-19

Table 31: US 15-Year Perspective for Clinical Diagnostics
Automation by Segment - Percentage Breakdown of Revenues for
Automated Analyzers, Total Lab Automation and Stand-alone
Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-20

2. CANADA III-21
A.Market Analysis III-21
Outlook III-21
Strategic Corporate Development III-21
B.Market Analytics III-22
Table 32: Canadian Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-22

Table 33: Canadian Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-23

Table 34: Canadian 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-24

3. JAPAN III-25
Market Analysis III-25
Table 35: Japanese Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-26

Table 36: Japanese Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-27

Table 37: Japanese 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-28

4. EUROPE III-29
A.Market Analysis III-29
European Clinical Diagnostics Automation Market: A Prelude III-29
Clinical Diagnostics Market: An Overview III-30
Table 38: Diagnostics Market in Europe (2012): Percentage
Share Breakdown of Revenues by Medical Imaging, Laboratory
Testing, and Anatomic Pathology (includes corresponding
Graph/Chart) III-30
Debt Crisis in Europe Affects Healthcare Industry III-31
Increasing Testing Needs of the Elderly: Business Case for
Lab Automation III-31
Table 39: Population Breakup by Age Group for Select
European Countries: 2012 (As a % of Total Population)
(includes corresponding Graph/Chart) III-32
Manufacturers Face Significant Challenges III-33
Automation Supports Growth in West European IVD Market III-33
B.Market Analytics III-34
Table 40: European Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Revenue Figures
in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-34

Table 41: European Historic Review for Clinical Diagnostics
Automation by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Revenue Figures in US$ Thousand for
Years 2006 through 2012 (includes corresponding Graph/Chart) III-35

Table 42: European 15-Year Perspective for Clinical
Diagnostics Automation by Geographic Region - Percentage
Breakdown of Revenues for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-36

Table 43: European Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-37

Table 44: European Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-38

Table 45: European 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-39

4a. FRANCE III-40
A.Market Analysis III-40
Key Players III-40
B.Market Analytics III-42
Table 46: French Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-42

Table 47: French Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-43

Table 48: French 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-44

4b. GERMANY III-45
A.Market Analysis III-45
Product Launch III-45
B.Market Analytics III-46
Table 49: German Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-46

Table 50: German Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-47

Table 51: German 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-48

4c. ITALY III-49
Market Analysis III-49
Table 52: Italian Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-49

Table 53: Italian Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-50

Table 54: Italian 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-51

4d. THE UNITED KINGDOM III-52
A.Market Analysis III-52
Product launch III-52
B.Market Analytics III-53
Table 55: UK Recent Past, Current and Future Analysis for
Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-53

Table 56: UK Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-54

Table 57: UK 15-Year Perspective for Clinical Diagnostics
Automation by Segment - Percentage Breakdown of Revenues for
Automated Analyzers, Total Lab Automation and Stand-alone
Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-55

4e. SPAIN III-56
Market Analysis III-56
Table 58: Spanish Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-56

Table 59: Spanish Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-57

Table 60: Spanish 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-58

4f. RUSSIA III-59
Market Analysis III-59
Table 61: Russian Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-59

Table 62: Russian Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-60

Table 63: Russian 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-61

4g. REST OF EUROPE III-62
A.Market Analysis III-62
Product Launches III-62
Strategic corporate development III-62
Key Players III-62
B.Market Analytics III-64
Table 64: Rest of Europe Recent Past, Current and Future
Analysis for Clinical Diagnostics Automation by Segment -
Automated Analyzers, Total Lab Automation and Stand-alone
Automation Independently Analyzed with Annual Revenue
Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-64

Table 65: Rest of Europe Historic Review for Clinical
Diagnostics Automation by Segment - Automated Analyzers,
Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-65

Table 66: Rest of Europe 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-66

5. ASIA-PACIFIC III-67
A.Market Analysis III-67
Outlook III-67
Healthcare Spending in Asia-Pacific: On the Rise III-67
B.Market Analytics III-68
Table 67: Asia-Pacific Recent Past, Current and Future
Analysis for Clinical Diagnostics Automation by Geographic
Region - China, India and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-68

Table 68: Asia-Pacific Historic Review for Clinical
Diagnostics Automation by Geographic Region - China, India
and Rest of Asia-Pacific Markets Independently Analyzed with
Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-69

Table 69: Asia-Pacific 15-Year Perspective for Clinical
Diagnostics Automation by Geographic Region - Percentage
Breakdown of Revenues for China, India and Rest of
Asia-Pacific Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-70

Table 70: Asia-Pacific Recent Past, Current and Future
Analysis for Clinical Diagnostics Automation by Segment -
Automated Analyzers, Total Lab Automation and Stand-alone
Automation Independently Analyzed with Annual Revenue
Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-71

Table 71: Asia-Pacific Historic Review for Clinical
Diagnostics Automation by Segment - Automated Analyzers,
Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-72

Table 72: Asia-Pacific 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-73

5a. CHINA III-74
A.Market Analysis III-74
Outlook III-74
Healthcare Reforms: Opportunities for Clinical Labs Market III-74
B.Market Analytics III-75
Table 73: Chinese Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-75

Table 74: Chinese Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-76

Table 75: Chinese 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-77

5b. INDIA III-78
A.Market Analysis III-78
Automation of Clinical Laboratories on the Rise III-78
Challenges Abound in the Indian Clinical Diagnostics Labs
Market III-78
Private Enterprises Encourage Changes in Diagnostics Sector III-79
Indian Blood Gas and Electrolyte Analyzers Market III-79
Table 76: Indian Blood Gas and Electrolyte Analyzers and
Reagents (2013): Percentage Breakdown of Value and Volume
Sales by Segment (includes corresponding Graph/Chart) III-79
A List of Key Vendors in the Indian Blood Gas and
Electrolyte Analyzers and Reagents Market III-80
Product launches III-80
B.Market Analytics III-81
Table 77: Indian Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-81

Table 78: Indian Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-82

Table 79: Indian 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-83

5c. REST OF ASIA-PACIFIC III-84
A.Market Analysis III-84
Outlook III-84
Singapore III-84
B.Market Analytics III-85
Table 80: Rest of Asia-Pacific Recent Past, Current and
Future Analysis for Clinical Diagnostics Automation by
Segment - Automated Analyzers, Total Lab Automation and
Stand-alone Automation Independently Analyzed with Annual
Revenue Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-85

Table 81: Rest of Asia-Pacific Historic Review for Clinical
Diagnostics Automation by Segment - Automated Analyzers,
Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-86

Table 82: Rest of Asia-Pacific 15-Year Perspective for
Clinical Diagnostics Automation by Segment - Percentage
Breakdown of Revenues for Automated Analyzers, Total Lab
Automation and Stand-alone Automation for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-87

6. LATIN AMERICA III-88
Market Analysis III-88
Table 83: Latin American Recent Past, Current and Future
Analysis for Clinical Diagnostics Automation by Geographic
Region - Brazil and Rest of Latin America Markets
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-88

Table 84: Latin American Historic Review for Clinical
Diagnostics Automation by Geographic Region - Brazil and
Rest of Latin America Markets Independently Analyzed with
Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-89

Table 85: Latin American 15-Year Perspective for Clinical
Diagnostics Automation by Geographic Region - Percentage
Breakdown of Revenues for Brazil and Rest of Latin America
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-90

Table 86: Latin American Recent Past, Current and Future
Analysis for Clinical Diagnostics Automation by Segment -
Automated Analyzers, Total Lab Automation and Stand-alone
Automation Independently Analyzed with Annual Revenue
Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-91

Table 87: Latin American Historic Review for Clinical
Diagnostics Automation by Segment - Automated Analyzers,
Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-92

Table 88: Latin American 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-93

6a. BRAZIL III-94
A.Market Analysis III-94
Outlook III-94
Clinical Diagnostics Automation Market Poised to Grow III-94
Table 89: Brazilian Clinical Diagnostics Automation Market
(2011): Market Share Breakdown by Leading Companies -
Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare,
and Others (includes corresponding Graph/Chart) III-94
B.Market Analytics III-95
Table 90: Brazilian Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-95

Table 91: Brazilian Historic Review for Clinical Diagnostics
Automation by Segment - Automated Analyzers, Total Lab
Automation and Stand-alone Automation Independently Analyzed
with Annual Revenue Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-96

Table 92: Brazilian 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-97

6b. REST OF LATIN AMERICA III-98
Market Analysis III-98
Table 93: Rest of Latin American Recent Past, Current and
Future Analysis for Clinical Diagnostics Automation by
Segment - Automated Analyzers, Total Lab Automation and
Stand-alone Automation Independently Analyzed with Annual
Revenue Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-98

Table 94: Rest of Latin American Historic Review for
Clinical Diagnostics Automation by Segment - Automated
Analyzers, Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Revenue Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-99

Table 95: Rest of Latin American 15-Year Perspective for
Clinical Diagnostics Automation by Segment - Percentage
Breakdown of Revenues for Automated Analyzers, Total Lab
Automation and Stand-alone Automation for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-100

7. REST OF WORLD III-101
A.Market Analysis III-101
Outlook III-101
South Africa III-101
Major Challenges Impeding Laboratory Automation in Africa III-101
B.Market Analytics III-103
Table 96: Rest of World Recent Past, Current and Future
Analysis for Clinical Diagnostics Automation by Segment -
Automated Analyzers, Total Lab Automation and Stand-alone
Automation Independently Analyzed with Annual Revenue
Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-103

Table 97: Rest of World Historic Review for Clinical
Diagnostics Automation by Segment - Automated Analyzers,
Total Lab Automation and Stand-alone Automation
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-104

Table 98: Rest of World 15-Year Perspective for Clinical
Diagnostics Automation by Segment - Percentage Breakdown of
Revenues for Automated Analyzers, Total Lab Automation and
Stand-alone Automation for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-105


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 57 (including Divisions/Subsidiaries - 62)

The United States (37)
Canada (2)
Japan (1)
Europe (19)
- France (3)
- Germany (3)
- The United Kingdom (6)
- Italy (1)
- Rest of Europe (6)
Asia-Pacific (Excluding Japan) (3)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...

Chemical and Physical Analysis Equipment Markets in Asia to 2018 - Market Size, Trends, and Forecasts

Chemical and Physical Analysis Equipment Markets in Asia to 2018 - Market Size, Trends, and Forecasts

  • $ 7 302
  • Industry report
  • August 2014
  • by Global Research & Data Services

This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for chemical and physical analysis equipment in different Asian countries. ...

G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets

G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

This report elaborates on the present landscape for major segments of the GPCR drug market, discusses and relates the future trends and strategies to the breakthrough developments within the market. The ...

Global Immunoassay Systems Market

September 2014 $ 4 950

Global Cholesterol Testing Market

September 2014 $ 4 950

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.